Literature DB >> 6870226

Cefonicid concentrations in serum and atrial tissue during open-heart surgery.

R P Sterling, D J Connor, J C Norman, D A Cooley.   

Abstract

Cefonicid was administered intramuscularly 1 h before open-heart surgery to seven patients in doses of 1 g each and to six patients in doses of 2 g each. Cefonicid concentrations were measured in the right atrial biopsy and in serum at onset of surgery, at time of atrial biopsy, 15 min after starting cardiopulmonary bypass, and at completion of cardiopulmonary bypass. Concentrations in the atrial biopsy and in serum at all periods exceeded the minimal inhibitory concentrations for organisms most frequently responsible for postoperative infections.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6870226      PMCID: PMC184821          DOI: 10.1128/AAC.23.5.790

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  A double-blind clinical trial of prophylactic antibiotics in hip fractures.

Authors:  R J Boyd; J F Burke; T Colton
Journal:  J Bone Joint Surg Am       Date:  1973-09       Impact factor: 5.284

2.  Postoperative wound infection: a prospective study of determinant factors and prevention.

Authors:  H C Polk; J F Lopez-Mayor
Journal:  Surgery       Date:  1969-07       Impact factor: 3.982

3.  Comparative trial of cefonicid and cefamandole in the therapy of community-acquired pneumonia.

Authors:  R J Wallace; S L Niefield; S Waters; B Waters; R J Awe; K Wiss; R R Martin; S B Greenberg
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

4.  Cephalothin prophylaxis in cardiac valve surgery. A prospective, double-blind comparison of two-day and six-day regimens.

Authors:  D A Goldmann; C C Hopkins; A W Karchmer; R M Abel; M T McEnany; C Akins; M J Buckley; R C Moellering
Journal:  J Thorac Cardiovasc Surg       Date:  1977-03       Impact factor: 5.209

5.  Kinetics and renal handling of cefonicid.

Authors:  D Pitkin; J Dubb; P Actor; F Alexander; S Ehrlich; R Familiar; R Stote
Journal:  Clin Pharmacol Ther       Date:  1981-11       Impact factor: 6.875

6.  Antibiotic prophylaxis in vascular surgery.

Authors:  A B Kaiser; K R Clayson; J L Mulherin; A C Roach; T R Allen; W H Edwards; W A Dale
Journal:  Ann Surg       Date:  1978-09       Impact factor: 12.969

7.  Distribution of sodium cefazolin in serum, muscle, bone marrow, and bone of normal rabbits.

Authors:  D H Pitkin; C Sachs; I Zajac; P Actor
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

  7 in total
  3 in total

1.  Comparative penetration of cefonicid and cefazolin into the atrial appendage and pericardial fluid of patients undergoing open-heart surgery.

Authors:  M N Dudley; C H Nightingale; A D Drezner; H B Low; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

Review 2.  Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  E Saltiel; R N Brogden
Journal:  Drugs       Date:  1986-09       Impact factor: 9.546

3.  Azlocillin and cefonicid penetration into bone enhanced by probenecid.

Authors:  J T Summersgill; L G Harrod; M J Raff
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.